FDA Approved: CAPECITABINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for capecitabine from Teva Pharmaceuticals USA, Inc., indicating an update to its labeling or indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

SUPPL AP for CAPECITABINE (CAPECITABINE)